Introduction
Toxic oxygen metabolites have been postulated to participate in acute ischemic and hypoxic myocardial injury (Chambers et al., 1985 ; McCord, 1985) . Although they may come from many sources, recent studies have emphasized the potential importance of xanthine oxidase which is formed from xanthine dehydrogenase during ischemia or hypoxia (McCord, 1985; Hearse et al., 1986; Parks and Granger, 1986) . Indeed, inhibition of xanthine oxidase or limitation of substrate availability for the enzyme does minimize injury in some animal models. However, not all animal models conform to this scheme. In particular,
we and others have shown that the ischemic/reperfused rabbit heart does not contain either xanthine oxidase or dehydrogenase (Grum et al., 1986 (Grum et al., , 1987a Downey et al., 1988) . 'Therefore, it appears likely that the myocardial xanthine oxidase system may be more important in some species (e.g. dog, ratj than in others (e.g. rabbit, pig). Species variability raises questions about the applicability of the xanthine oxidase hypothesis to human myocardium.
The sparse human data available have yielded conflicting results. Using a variety of enzyme assays and tissue sampling procedures, investigators have reported no xanthine oxidase activity (Ramboer, 1969; Eddy et al., 1987) , minute levels of activity (Watts et al., 1965; Muxfeldt and Schaper, 1987) , or relatively high levels of activity (Bruder et al., 1984) . Using a previously validated sensitive radiochemical assay (Grum et al., 1986) , we report the absence of measurable xanthine oxidase or dehydrogenase activity in human myocardium.
Materials and Methods
Human heart studies A The biopsies were obtained by a small cutting forceps, similar to those used for polypectomy during colonscopy. The biopsies were frozen within 10 s by immersion in liquid nitrogen, and stored at -80°C. Biopsies were processed as described below.
Rat heart studies
To assess the ability of the enzyme assays to detect activity in small tissue samples, biopsies were obtained from the left ventricular myocardium of six Sprague-Dawley rats that were killed by decapitation.
The hearts were immediately biopsied in situ with a forceps identical to that used for human hearts. Biopsies were frozen immediately in liquid nitrogen, stored, and processed as described below.
Tissue preparation
Frozen biopsies were weighed and immediately placed in 1 ml of an ice cold buffer (PH 9.0) containing 0.125 M Tris(hydroxymethyl)aminomethane, 10 mM dithiothreitol (DTT), 1 mM phenylmethylsulfonyl fluoride (PMSF), and 0.1 mM EDTA. The DTT and PMSF were added to prevent in vitro conversion of xanthine dehydrogenase to xanthine oxidase. The tissue was homogenized in the ice cold buffer. The homogenate was spun at 12 000 g for 20 min at 4°C. The supernatant was dialyzed at 4°C in a 200 : 1 dilution of buffer overnight to remove enzyme inhibitors and endogenous purines. Aliquots were then assayed for enzyme activity.
Enzyme assg
The radiochemical assay for xanthine oxidase/xanthine dehydrogenase is identical to that which we have described before (Grum et al., 1986) . In brief, we optimized enzyme activity according to the method of Mousson et al. (1983) . The reaction mixture contained buffer, [8-14C] hypoxanthine, and sample, at 37"C, in a shaking water bath. Six aliquots of each sample were reacted with the radiolabeled hypoxanthine in the presence or absence of NAD+ ( 1 mM final concentration), perchloric acid (283 mM), or allopurinol ( 1 mM).
This enabled us to assess, individually, the activities of xanthine oxidase alone, xanthine oxidase plus xanthine dehydrogenase, pharmacologic inhibition by allopurin-01, and baseline counts. Sample counts W~I'C adjusted by subtracting the background counts obtained in the perchloric acid-treated controls. The reaction was run for 15 min, since reaction rates become nonlinear thereafter (Watts et al., 19651 . All reactions were stopped by adding perchloric acid and immediately chilling the reaction mixtures in ice. The reaction mixture was spotted on electrophoresis paper. Substrate and products were separated with high voltage electrophoresis. The spots were identified under U.V. light, cut. and radioactivity was counted by liquid scintillation spectrometry.
Enzyme activity was computed and expressed as milliinternational units/g of wet tissue weight. One mIU corresponds to one nmol of hypoxanthine oxidized/ min.
Results
The nine human myocardial biopsies weighed 13 f 2 mg (mean f s.E.M.). The rat heart biopsies weighed 13 k 1 mg (not significantly different from human biopsy weights; P > 0.8, t-test).
No xanthine oxidase or xanthine dehydrogenase activity was detected in the human myocardial samples. Under conditions used to assay xanthine oxidase plus xanthine dehydrogenase activity of the human samples, the radioactivity of the electrophoresis spots containing xanthine plus uric acid did not exceed the background radioactivity.
The corresponding activity measured under conditions to assess xanthine oxidase activity alone also did not exceed background radioactivity.
The addition of allopurinol (1 mM) to both these assays had no effect. These findings indicate that there is no xanthine oxidase or xanthine dehydrogenase activity present in human myocardial samples based on this assay.
In order to confirm our findings, we obtained larger pieces (150 and 589 mg) of human myocardium at the time of cardiac transplantation in two patients. This tissue was assayed using the same procedures used for the biopsies. There was no evidence of xanthine dehydrogenase or xanthine oxidase activity.
In contrast, with rat myocardial samples, radioactivity of the xanthine and uric acid spots obtained under conditions measuring Rat heart biopsies (n = 6) 98.1 f 24.3 54.9 f 17.7 43.2 f 14.5 Human heart biopsies (n = 9) 0 0 0 Human heart transplant (n = 2) 0 0 0 samples * XOjXD, combined xanthine oxidase and dehydrogenase activity; X0, xanthine oxidase activity; XD, xanthine dehydrogenase activity both xanthine oxidase and dehydrogenase exceeded background by 1281 + 308 ct/min (P < 0.001 ; t-test). The corresponding counts for xanthine oxidase alone exceeded background by 682 f 132 ct/min (P < 0.001; t-testi. The counts per minute for rat myocardial samples run in the presence of allopurinol were not different from background counts (P > 0.4; t-test). This indicated that allopurinol completely inhibited xanthine oxidase activity. The computed enzyme activities are shown in Table 1 . Total enzyme activity joxidase plus dehydrogenase) was only slightly higher than that which we have previously reported for whole rat hearts (62 mIU/g wet wt; Grum et al., 1986) , or the value reported by Eddy et al. (1987 ;  77 mIU/g wet wt). However, our microsampling technique resulted in a greater percentage of the enzyme in the oxidase form. We believe manipulation and processing of the small biopsies caused the increased conversion of xanthine oxidase to dehydrogenase.
Discussion
Our main finding is that we did not detect any xanthine oxidase or dehydrogenase activity in human myocardial biopsies. This supports the data of Eddy et al. (1987) , that in terms of xanthine oxidase, human myocardium appears more similar to rabbit myocardium than to rat or dog myocardium. Our present study using a sensitive radiochemical assay corroborates the postulate of Downey et al. ( 1988) (1987) , using a standard spectrophotometric assay, have reported barely detectable (0.013 nmol/min/g wet wtj xanthinc oxidase activity in tissue from one human heart obtained during surgery. This level of activity is lower than that found in the hearts of other species with the exception of the rabbit heart. On the other hand, the preliminary finding by deJong et al. (19871 that human heart can produce significant amounts of uric acid had led them to conclude that xanthine oxidase activity is present. Jarasch and coworkers have noted immunofluorescent staining of human myocardial capillaries using xanthine oxidase antibodies (Bruder et al., 1984; Jarasch et al., 1986) . However, they used antibodies to milk xanthine oxidase, and human myocardium may possess an enzyme form that is neither xanthine oxidase nor dehydrogenase but can cross-react with the antibody (Downey et al., 1988) . Jarasch and colleagues therefore did not report xanthine oxidase activity, but the presence of matertar that reacts to anti-bovine xanthine oxidase antibodies. The most convincing evidence for the lack of xanthine oxidase in human heart used a modified spectrophotometric assay (Eddy et al., 1987) ) applied to heart samples from four patients. They used matched allopurinol controls to compensate for the unknown peak which coabsorbs with uric acid. We obtained the same outcome using a very sensitive radiochemical assay that has been thoroughly validated in the past, both by others (Mousson et al., 1983 ; Sinclair and Fox, 1975) and in our previous experiments (Grum et al., 1986) . In addition, our methods for processing and analyzing the human myocardial biopsies were identical to those used for rat myocardial biopsies, a species characterized by relatively high levels of xanthine oxidase and dehydrogenase.
Thus we concur that xanthine oxidase and xanthine dehydrogenase do not exist (or exist at very low concentrations) in the human myocardium.
This enzyme system therefore is not likely to be important in ischemic/ reperfusion injury of the human heart. In choosing an experimental model of ischemiareperfusion injury that realistically simulates human myocardial injury, we propose that a model devoid of xanthine oxidase may be the most appropriate.
In rat and dog ischemicreperfusion injury, xanthine oxidase generation of oxygen radicals appears to play a major role. Data at this point suggests that the rabbit model, and possibly the pig model, may be the most rational option to examine human ischemic/reperfusion myocardial injury (Grum et al., 1986 (Grum et al., , 1987a Muxfeldt and Schaper, 1987; Downey et al., 1988) .
Studies of the xanthine oxidase and dehydrogenase system may nonetheless be relevant to human disease. Xanthine oxidase and dehydrogenase are present in human liver and small intestine in high concentrations (Mousson et al., 1983) . In some forms of acute diffuse lung injury, and in acute liver injury, xanthine oxidase is present in human plasma and therefore could be transported to the myocardium (Shamma'a et al., 1965 ; Grum et al., 198713 ). Toxic oxygen metabolites could then be generated when the circulating xanthine oxidase reacts with the increased purines formed during ischemic myocardial episodes. In addition, human neutrophils may contain xanthine oxidase (Jones et al., 1985) . Finally, studies of xanthine oxidase inhibitors, (e.<g. allopurinol) have shown beneficial effect on injury by a pathway not related to enzyme inhibition (Myers et al., 1985 (Myers et al., , 1986 Downey et al., 1988) 
